Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by JTE-522, a selective COX-2 inhibitor

Carcinogenesis

Volumn 22, Issue 4, 2001, Pages 547-551

  Li, Zhigang ^a   Shimada, Yutaka ^a   Kawabe, Atsushi ^a   Sato, Fumiaka ^a   Maeda, M Masato ^a   Komoto, Izumi ^a   Hong, Tao ^a   Ding, Yongzeng ^a   Kaganoi, Junichi ^a   Imamura, Masayuk ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; MESSENGER RNA; N BENZYL N METHYLNITROSAMINE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR; TILMACOXIB;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER; CANCER INHIBITION; CARCINOGENESIS; CLINICAL OBSERVATION; CONTROLLED STUDY; DRUG INTERMITTENT THERAPY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGUS CARCINOMA; ESOPHAGUS MUCOSA; GENE OVEREXPRESSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RAT; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VOLUME;

ANIMALS; BENZENESULFONATES; BODY WEIGHT; CARCINOGENS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DIMETHYLNITROSAMINE; DINOPROSTONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; ISOENZYMES; MALE; OXAZOLES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, INBRED F344; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0035067428     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/22.4.547     Document Type: Article

References (37)

1. Metabolism of arachidonic acid in human lung cancer cell lines
2. Induction of cyclooxygenase-2 mRNA by prostaglandin E2 in human prostatic carcinoma cells
3. Deleterious effects of prostaglandin E2 in esophageal carcinogenesis
4. Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo
5. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells
6. Cyclooxygenase regulates angiogenesis induced by colon cancer cells
7. PGE2 and angiogenesis
8. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues
9. Different catalytically competent arrangements of arachidonic acid within the cyclooxygenase active site of prostaglandin endoperoxide H synthase-1 lead to the formation of different oxygenate products
10. Regulation of cyclooxygenase-2 by interferon gamma and transforming growth factor alpha in normal human epidermal keratinocytes and squamous carcinoma cells. Role of mitogen-activated protein kinases
11. Expression of cyclooxygenase-1 and -2 in human colorectal cancer
12. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas
13. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer
14. Expression of cyclooxygenase-2 in human gastric carcinoma
15. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer
16. Cyclooxygenase-2 expression in human esophageal carcinoma
17. Expression of cyclooxygenase-1 and cyclooxygenase-2 in N-nitrosomethyl-benzylamine-induced rat esophageal tumorigenesis
18. A better understanding of anti-inflammatory drugs based on isoforms of cyclooxygenase (COX-1 and COX-2)
19. Aspirin use and reduced risk of fatal colon cancer
20. Role of diet and NSAIDs in the chemoprevention of colorectal cancer
21. Aspirin and reduced risk of esophageal carcinoma
22. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs
23. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis
24. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells
25. 2+ release mediates ursolic acid-induced apoptosis in human leukemic HL-60 cells
26. The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2
27. Pharmacological profile of JTE-522, a novel prostaglandin H synthase-2 inhibitor, in rats
28. Inhibitory effects of JTE-522, a novel prostaglandin H synthase-2 inhibitor, on adjuvant-induced arthritis and bone changes in rats
29. Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522
30. A selective cyclooxygenase-2 inhibitor suppresses tumor growth in nude mouse xenografted with human head and neck squamous carcinoma cells
31. The effect of estrone-progesterone treatment on cell proliferation kinetics of hormone-dependent GR mouse mammary tumors
32. Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus
33. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis
34. Chemopreventive effect of curcumin on N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in rats
35. Review: Cyclooxygenase-2 inhibitors in tumorigenesis (Part I)
36. Induction of cyclooxygenase-2 mRNA by prostaglandin E2 in human prostatic carcinoma cells
37. Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen